The nuclear hub network enrichment was driven by genes implicated in Alzheimer’s disease (APOE), non-alcoholic drug-related phenotypes (RAB4B-EGLN2), and cognitive ability (LRRN2 and MAPT). This evidence concerns the gene MAPT and Alzheimer disease.